Bridgeway Capital Management’s Icosavax, Inc. Common Stock ICVX Stock Holding History

Bridgeway Capital Management’s Portfolio ICVX Stock Details ICVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-35,000	Closed	-$271K	–	1442
2023 Q3	$271K	Hold	35,000	–	–	0.01%	1032
2023 Q2	$348K	Sell	35,000 -33,052	-49%	-$265K	0.01%	1005
2023 Q1	$395K	Sell	68,052 -20,000	-23%	-$173K	0.01%	938
2022 Q4	$699K	Sell	88,052 -30,000	-25%	-$129K	0.02%	809
2022 Q3	$373K	Buy	+118,052	New	+$738K	0.01%	972

Other funds holding ICVX

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

QUSVM

Qiming U.S. Ventures Management Bellevue, Washington $55.6M AUM 98.09% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Bridgeway Capital Management's ICVX Position: Q4 2023 in Review

Bridgeway Capital Management sold out of Icosavax, Inc. Common Stock (ICVX) in Q4 2023, closing a stake of 35,000 shares — an estimated $271K sold.

Bridgeway Capital Management first reported a position in ICVX in Q3 2022 and held it in 5 quarters. The position peaked at $699K in Q4 2022. 93 funds tracked by Wall St. Rank hold ICVX as of Q4 2023.

Bridgeway Capital Management reported no remaining Icosavax, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Bridgeway Capital Management sold 35,000 Icosavax, Inc. Common Stock shares in Q4 2023, an estimated $271K.
Bridgeway Capital Management first reported a position in Icosavax, Inc. Common Stock in Q3 2022 and held it in 5 quarters.
Bridgeway Capital Management's Icosavax, Inc. Common Stock position peaked at $699K in Q4 2022.
93 funds tracked by Wall St. Rank held Icosavax, Inc. Common Stock as of Q4 2023.

Based on Bridgeway Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.